TACHYBEN 100mg perfusive solution concentrate medication leaflet

C02CA06 urapidil • Cardiovascular system | Antiadrenergic agents, peripherally acting | Alpha-adrenoreceptor antagonists

Urapidil is a medication used in the treatment of hypertension, particularly in cases of hypertensive emergencies. It acts as an antagonist of alpha-1 adrenergic receptors and an agonist of serotonin 5-HT1A receptors, providing a rapid and controlled reduction in blood pressure.

Urapidil is administered intravenously in acute situations or orally for long-term hypertension management. The dosage and administration method are determined by the physician based on the severity of the condition and the patient's response to treatment.

Common side effects include dizziness, headache, nausea, and fatigue. In rare cases, allergic reactions or severe hypotension may occur. It is important to use urapidil under strict medical supervision, especially in patients with other cardiovascular conditions.

Urapidil is an effective medication for controlling hypertension, helping to reduce the risk of serious complications such as stroke or myocardial infarction.

General data about TACHYBEN 100mg

Substance: urapidil

Date of last drug list: 01-06-2025

Commercial code: W58331001

Concentration: 100mg

Pharmaceutical form: perfusive solution concentrate

Quantity: 5

Product type: generic

Price: 200.41 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: CENEXI - FRANTA

Holder: EVER NEURO PHARMA GMBH - AUSTRIA

Number: 10555/2018/01

Shelf life: 3 years-after packing for marketing; dupa dilutie-se utlizeaza imediat

Concentrations available for urapidil

100mg, 25mg, 25mg/5ml, 50mg, 50mg/10ml

Other substances similar to urapidil